These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Aberrant pre-receptor regulation of estrogen and progesterone action in endometrial cancer. Smuc T; Rizner TL Mol Cell Endocrinol; 2009 Mar; 301(1-2):74-82. PubMed ID: 18930784 [TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of aromatase, sulfatase and 17beta-HSD(1) mRNA expression in soft tissue metastases of breast cancer. Irahara N; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S Cancer Lett; 2006 Nov; 243(1):23-31. PubMed ID: 16556483 [TBL] [Abstract][Full Text] [Related]
8. Estrogen inhibits cell proliferation through in situ production in human thymoma. Ishibashi H; Suzuki T; Suzuki S; Moriya T; Kaneko C; Nakata T; Sunamori M; Handa M; Kondo T; Sasano H Clin Cancer Res; 2005 Sep; 11(18):6495-504. PubMed ID: 16166425 [TBL] [Abstract][Full Text] [Related]
9. Analysis of aromatase and 17beta-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression in deep endometriosis and eutopic endometrium using laser capture microdissection. Matsuzaki S; Canis M; Pouly JL; Déchelotte PJ; Mage G Fertil Steril; 2006 Feb; 85(2):308-13. PubMed ID: 16595205 [TBL] [Abstract][Full Text] [Related]
11. Stromal cells of endometriosis fail to produce paracrine factors that induce epithelial 17beta-hydroxysteroid dehydrogenase type 2 gene and its transcriptional regulator Sp1: a mechanism for defective estradiol metabolism. Cheng YH; Imir A; Fenkci V; Yilmaz MB; Bulun SE Am J Obstet Gynecol; 2007 Apr; 196(4):391.e1-7; discussion 391.e7-8. PubMed ID: 17403431 [TBL] [Abstract][Full Text] [Related]
12. Expression of 17beta-hydroxysteroid dehydrogenase type 2 in pelvic endometriosis. Carneiro MM; Morsch DM; Camargos AF; Spritzer PM; Reis FM Gynecol Endocrinol; 2007 Apr; 23(4):188-92. PubMed ID: 17505937 [TBL] [Abstract][Full Text] [Related]
13. Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol. Zeitoun K; Takayama K; Sasano H; Suzuki T; Moghrabi N; Andersson S; Johns A; Meng L; Putman M; Carr B; Bulun SE J Clin Endocrinol Metab; 1998 Dec; 83(12):4474-80. PubMed ID: 9851796 [TBL] [Abstract][Full Text] [Related]
15. Intratumoral concentration of sex steroids and expression of sex steroid-producing enzymes in ductal carcinoma in situ of human breast. Shibuya R; Suzuki T; Miki Y; Yoshida K; Moriya T; Ono K; Akahira J; Ishida T; Hirakawa H; Evans DB; Sasano H Endocr Relat Cancer; 2008 Mar; 15(1):113-24. PubMed ID: 18310280 [TBL] [Abstract][Full Text] [Related]
16. Steroid metabolism in breast cancer. Foster PA Minerva Endocrinol; 2008 Mar; 33(1):27-37. PubMed ID: 18277377 [TBL] [Abstract][Full Text] [Related]
17. The role of estrogen-metabolizing enzymes and estrogen receptors in human epidermis. Inoue T; Miki Y; Abe K; Hatori M; Hosaka M; Kariya Y; Kakuo S; Fujimura T; Hachiya A; Aiba S; Sasano H Mol Cell Endocrinol; 2011 Sep; 344(1-2):35-40. PubMed ID: 21740958 [TBL] [Abstract][Full Text] [Related]
18. An assessment of the multifactorial profile of steroid-metabolizing enzymes and steroid receptors in the eutopic endometrium during moderate to severe ovarian endometriosis. Anupa G; Sharma JB; Roy KK; Sengupta J; Ghosh D Reprod Biol Endocrinol; 2019 Dec; 17(1):111. PubMed ID: 31878927 [TBL] [Abstract][Full Text] [Related]
19. Estrogen formation in endometrial and cervix cancer cell lines: involvement of aromatase, steroid sulfatase and 17beta-hydroxysteroid dehydrogenases (types 1, 5, 7 and 12). Fournier MA; Poirier D Mol Cell Endocrinol; 2009 Mar; 301(1-2):142-5. PubMed ID: 18817841 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of type 1 17β-hydroxysteroid dehydrogenase impairs the synthesis of 17β-estradiol in endometriosis lesions. Delvoux B; D'Hooghe T; Kyama C; Koskimies P; Hermans RJ; Dunselman GA; Romano A J Clin Endocrinol Metab; 2014 Jan; 99(1):276-84. PubMed ID: 24187399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]